Plus   Neg

Hi-Tech Pharmacal (HITK) Surged To A 2-Month High On Q2 Results

Hi-Tech Pharmacal (HITK) reported second quarter net income of $0.66 per share Thursday morning, down from $1.04 per share last year. The consensus estimate was for EPS of $0.53. Revenues improved to $57.5 million from $56.9 million last year. Analysts expected revenues of $55.04 million.

Hi-Tech Pharmacal gapped open higher Thursday and rose steadily throughout the first hour of trade. The stock closed up by 4.20 at $35.25 on above average volume and set a 2-month high.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT